Osteopontin and Cancer: Insights into Its Role in Drug Resistance

被引：17
|
作者：
Hao, Chengcheng [1 ,2 ]
Lane, Jane [2 ]
Jiang, Wen G. [2 ]
机构：
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Oncol, Beijing 100038, Peoples R China
[2] Cardiff Univ, Div Canc & Genet, Cardiff China Med Res Collaborat, Sch Med, Heath Pk, Cardiff CF14 4XN, Wales
来源：
BIOMEDICINES | 2023年 / 11卷 / 01期
关键词：
osteopontin; cancer; drug resistance; molecular mechanism; LUNG-CANCER; EPIGENETIC MODIFICATIONS; EXPRESSION; CELLS; AUTOPHAGY; CISPLATIN; SENSITIVITY; BIOMARKER; HETEROGENEITY; MECHANISMS;
D O I：
10.3390/biomedicines11010197
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Cancer is one of the leading causes of mortality worldwide. Currently, drug resistance is the main obstacle in cancer treatments with the underlying mechanisms of drug resistance yet to be fully understood. Osteopontin (OPN) is a member of the integrin binding glycophosphoprotein family that is overexpressed in several tumour types. It is involved in drug transport, apoptosis, stemness, energy metabolism, and autophagy, which may contribute to drug resistance. Thus, understanding the role of OPN in cancer drug resistance could be important. This review describes the OPN-based mechanisms that might contribute to cancer drug resistance, demonstrating that OPN may be a viable target for cancer therapy to reduce drug resistance in sensitive tumours.
引用
收藏
页数：18
相关论文
共 50 条
  • [31] The role of microvesicles in cancer progression and drug resistance
    Jorfi, Samireh
    Inal, Jameel M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 293 - 298
  • [32] The role of circRNA in breast cancer drug resistance
    Yang, Shaofeng
    Li, Donghai
    PEERJ, 2024, 12
  • [33] AN ELEMENTARY APPROACH TO MODELING DRUG RESISTANCE IN CANCER
    Tomasetti, Cristian
    Levy, Doron
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2010, 7 (04) : 905 - 918
  • [34] Cancer drug resistance: The central role of the karyotype
    Duesberg, Peter
    Li, Ruhong
    Sachs, Rainer
    Fabarius, Alice
    Upender, Madhvi B.
    Hehlmann, Ruediger
    DRUG RESISTANCE UPDATES, 2007, 10 (1-2) : 51 - 58
  • [35] Drug Resistance in Cancer Therapy and the Role of Epigenetics
    Asano, Takeshi
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2020, 87 (05) : 244 - 251
  • [36] A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors
    Leask, Andrew
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2020, 101 : 111 - 114
  • [37] Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer
    Gu, Tao
    Ohashi, Rina
    Cui, Ri
    Tajima, Ken
    Yoshioka, Masakata
    Iwakami, Shinichiro
    Sasaki, Shinichi
    Shinohara, Atsuko
    Matsukawa, Takehisa
    Kobayashi, Jun
    Inaba, Yutaka
    Takahashi, Kazuhisa
    LUNG CANCER, 2009, 66 (02) : 176 - 183
  • [38] The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis
    Xie, Yanchen
    Li, Hai-Feng
    Sun, Liang
    Kusner, Linda L.
    Wang, Shuhui
    Meng, Yunxiao
    Zhang, Xu
    Hong, Yu
    Gao, Xiang
    Li, Yao
    Kaminski, Henry J.
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [39] Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression
    Chen, Lang
    Huan, Xuan
    Xiao, Guo-Hui
    Yu, Wu-Han
    Li, Teng-Fei
    Gao, Xi -Dan
    Zhang, You-Cheng
    NEOPLASMA, 2022, 69 (06) : 1253 - 1269
  • [40] Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer
    Yang, Ruixue
    Yi, Mei
    Xiang, Bo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
12345